Cancer antigen 15-3 (CA15-3) in addition to carcinoembryonic antigen (CEA) along with cancer antigen 125 (CA125) are extensively used in the clinical practice of breast cancer as serum tumor markers. Here, CEACAM5 is linked to neoplasm.